Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children

NCT02728128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2020-03-04

No results posted yet for this study

Summary

The purpose of this study is to identify if circulating platelet cyclic adenosine monophosphate (cAMP) levels can be used as a biomarker of milrinone efficacy in children following cardiac surgery or undergoing heart transplant.

Conditions

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Katja M Gist, DO, MSCS · University of Colorado, Denver

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-08-17
Completion
2017-08-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02728128 on ClinicalTrials.gov